Improvements in insulin resistance and reductions in body weight increase lipoprotein lipase activity [19,20,21], which plays a key role in breaking down plasma TG from TG-rich lipoproteins, such as chylomicrons and very low density lipoproteins. The gene discussed is LPL; the disease is Insulin resistance.